However, the study protocol revealed several relevant limitations, i.e. a debatable PSA density cutoff and lack of biopsies in the PIRADS 3/3 + 1 subcohort without elevated PSA density [33] leading to a possibility of undetected prostate carcinomas in the cohort [34]. The gene discussed is KLK3; the disease is prostate carcinoma.